TVM just shy of €250m target

Technology and life science-focused venture capital firm TVM has raised €240.3 million from European, US and Asian investors to invest in drug discovery and development.

To view this content, you need to sign in.

You should only be asked to sign in once. Not the case? Click here

Register now to access this content and more for free.